ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE GALECTINA- 3
Mexico·Clase II·III. Agentes de
diagnóstico·ABBOTT LABORATORIES
DE MÉXICO, S.A. DE C.V.·Registered March 20, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ARCHITECT GALECTIN-3
- Trade Name (English)
- ARCHITECT GALECTIN-3
- Analysis ID
- 0750R2024 SSA
- Registration Date
- March 20, 2024
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE GALECTINA- 3 (ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE GALECTINA- 3) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 0750R2024 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on March 20, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.